Oxysterols suppress constitutive fibrinogen expression

Area of Science:

• Biochemistry
• Molecular Biology
• Cardiovascular Disease Research

Background:

• Elevated fibrinogen and cholesterol levels are known risk factors for coronary artery disease (CAD).
• Previous research indicated a metabolic link where fibrinogen overexpression in HepG2 cells increased cholesterol synthesis and apolipoprotein B secretion.

Purpose of the Study:

• To investigate the effect of oxysterols on fibrinogen expression.
• To explore a potential shared regulatory pathway between cholesterol homeostasis and fibrinogen synthesis.

Main Methods:

• Treatment of HepG2 cells, rat H-4-II-E hepatoma cells, and primary human hepatocytes with various oxysterols.
• Analysis of fibrinogen Aalpha, Bbeta, and gamma mRNA levels and protein synthesis.
• Assessment of effects on alpha1-antitrypsin and interleukin-6 treated cells.
• Investigation using SREBP-1/2 overexpression and LXRalpha agonist treatment.

Main Results:

• Oxysterols, specifically 25-hydroxycholesterol, significantly downregulated fibrinogen mRNA and inhibited its synthesis and secretion in HepG2 cells.
• This inhibitory effect was observed across different cell types, including primary human hepatocytes.
• Oxysterols reduced fibrinogen expression without affecting alpha1-antitrypsin, indicating specificity.
• Interleukin-6 treatment did not prevent oxysterol-mediated inhibition of fibrinogen synthesis.

Conclusions:

• Oxysterols play a role in downregulating fibrinogen expression, independent of acute-phase responses.
• These findings suggest a novel, shared regulatory pathway connecting cholesterol metabolism and fibrinogen production.
• Understanding this pathway could offer new therapeutic targets for managing CAD risk.